Arctic Vision, a China-based clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, announced on December 24th the clearance of the Investigational New Drug (IND) for Phase III trial of ARVN001 (triamcinolone ...
The system allows physicians and patients to combine therapeutic options, customize therapy and capture real-time feedback designed to treat chronic and debilitating pain successfully.
Under this collaboration, services offered by SCS at no cost, such as Pap smear, Mammogram and Faecal Immunochemical Test, can now be searched through BookDoc's free Apps and Website, BookDoc.com.